Knotnerus Tim Jasper bought AGMB

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002120886-26-000001

Machine-readable

Structured copy

Timestamps

Event (reported)

Oct 6, 2026

Published

Oct 7, 2026

Ingested by INSIDER

Nov 5, 02:12 UTC

Last re-read

Nov 5, 02:12 UTC

Extracted facts

Filer

Knotnerus Tim Jasper

Role

Director, Chief Executive Officer

Transaction

Open-market purchaseAs filed: “P”

Asset

AgomAb Therapeutics NV

Ticker

AGMB

Shares

5,000

Price per share

$8.7

Value

$43,500

Execution date (reported)

Oct 6, 2026

Owned after transaction

21.8K shares

Days from execution to publication

1

Calculation

What this establishes

Knotnerus Tim Jasper filed this Form 4 reporting a open-market purchase of AGMB on Oct 6, 2026. It became public on Oct 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, Chief Executive Officer

Knotnerus Tim Jaspercik:0002120886

Issuer

AgomAb Therapeutics NVcik:0002020932

Revision history · 0

No field has changed since this record was first ingested.